Molecular oncology and translational medicine

Immunotherapy in NSCLC: Adjuvant and neoadjuvant clinical scenarios

Adjuvant nivolumab vs placebo in resected oesophageal or gastroesophageal junction cancer following chemo: Biomarker analysis

Addressing cancer disparities in Hispanic populations in the US and in LMICs

Potential benefit to response rates from trastuzumab added to perioperative chemotherapy for patients with HER-2+ GC

Lenvatinib plus pembrolizumab versus standard of care for previously treated metastatic colorectal cancer

Botensilimab plus balstilimab for metastatic heavily pretreated microsatellite stable colorectal cancer

Whole exome sequencing reveals genomic landscape of appendiceal adenocarcinoma

The role of the workforce in implementing Choosing Wisely in cancer care

Rationale for routine use of IORT for early breast cancer and data for specific indications

The role of technology in value-based care

The role of provider assumptions in decreasing access to care in the LGBTQ community